Eleven new cannabinoid esters, together with three known cannabinoid acids and ∆ 9 -tetrahydrocannabinol (∆ 9 -THC), were isolated from a high-potency variety of Cannabis satiVa. The structures were determined by extensive spectroscopic analyses to be -fenchyl ∆ 9 -tetrahydrocannabinolate (1), epi-bornyl ∆ 9 -tetrahydrocannabinolate (2), R-terpenyl ∆ 9 -tetrahydrocannabinolate (3), 4-terpenyl ∆ 9 -tetrahydrocannabinolate (4), R-cadinyl ∆ 9 -tetrahydrocannabinolate (5), γ-eudesmyl ∆ 9 -tetrahydrocannabinolate (6), γ-eudesmyl cannabigerolate (7), 4-terpenyl cannabinolate (8), bornyl ∆ 9 -tetrahydrocannabinolate (9), R-fenchyl ∆ 9 -tetrahydrocannabinolate (10), R-cadinyl cannabigerolate (11), ∆ 9 -tetrahydrocannabinol (∆ 9 -THC), ∆ 9 -tetrahydrocannabinolic acid A (∆ 9 -THCA), cannabinolic acid A (CBNA), and cannabigerolic acid (CBGA). Compound 8 showed moderate antimicrobial activity against Candida albicans ATCC 90028 with an IC 50 value of 8.5 µg/mL. CB-1 receptor assay indicated that the esters, as well as the parent acids, are not active.
The medicinal properties of Cannabis have been much debated from scientific and political points of view, and the subject has lost and gained interest over the years. After the discovery of the primary active constituent in marijuana, ∆ 9 -THC, in 1964, 13 various clinical trials were undertaken to determine its efficacy as an analgesic, 14 antiemetic, 15 antidepressant, 16 and appetite suppressant 17 and for the treatment of glaucoma 18 and chemotherapyinduced nausea and vomiting. 19 The onset of HIV as a worldwide problem refocused marijuana as a possible symptom management drug and led to the discovery of the endocannabinoid (endogenous cannabinoid) system. 20 Features of this system include that cannabinoids act through receptors, that there are at least two types of receptors (CB1 21 and CB2 22 ), and that there are endogenous cannabinoid receptor agonists and antagonists (ligands). The CB1 receptor, uniquely recognized by cannabinoids, is found in brain and peripheral tissue of the central nervous system (CNS), 23 while the CB2 receptor is primarily found outside the CNS in tissues associated with immune function. 24 The availability of high-potency marijuana on the illicit market with unprecedented ∆ 9 -THC concentrations (>20% by dry weight) 25 has renewed our interest in the discovery of new constituents from C. satiVa L. We herein report the isolation and structure elucidation of 11 new esters from a high-potency variety of cannabis. These esters are -fenchyl ∆ 9 -tetrahydrocannabinolate (1), epi-bornyl ∆ 9 -tetrahydrocannabinolate (2), R-terpenyl ∆ 9 -tetrahydrocannabinolate (3), 4-terpenyl ∆ 9 -tetrahydrocannabinolate (4), R-cadinyl ∆ 9 -tetrahydrocannabinolate (5), γ-eudesmyl ∆ 9 -tetrahydrocannabinolate (6), γ-eudesmyl cannabigerolate (7), 4-terpenyl cannabinolate (8) , bornyl ∆ 9 -tetrahydrocannabinolate (9), R-fenchyl ∆ 9 -tetrahydrocannabinolate (10) , and R-cadinyl cannabigerolate (11) . In addition, four known cannabinoids were isolated, ∆ 9 -tetrahydrocannabinol (∆ 9 -THC), ∆ 9 -tetrahydrocannabinolic acid A (∆ 9 -THCA), cannabinolic acid A (CBNA), and cannabigerolic acid (CBGA). All isolated compounds were evaluated for antimicrobial and antimalarial activity, as well as CB-1 receptor binding.
Results and Discussion
Cannabis plant material was sequentially extracted with hexanes, CH 2 Cl 2 , EtOAc, EtOH, EtOH/H 2 O, and H 2 O. The hexanes extract was subjected to vacuum liquid chromatography (VLC) on flash silica gel. Fractions were combined according to their TLC profiles and chromatographed using flash silica gel eluting with hexanes. Fractions with R f higher than ∆ 9 -THC were combined and purified by flash silica gel and Sephadex LH-20 chromatography, followed by final purification by semipreparative reversed-phase (RP) and chiral HPLC. This yielded 11 new esters (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) .
The spectroscopic data of 1-6, 9, and 10 were similar to that of ∆ 9 -THCA, with the characteristic four methyls resonating at δ 1.67 (3H, s, H-11), 1.43 (3H, s, H-13), 1.09 (3H, s, H-12), and 0.88 (3H, t, J ) 6.4 Hz, H-5′), an aromatic proton signal at δ 6.23 (1H, s, H-4), and a broad olefinic resonance at δ 6.41 (1H, s, H-10) for 1 ( Table 1) . 26 Significant differences between these compounds and ∆ 9 -THCA were observed in the NMR spectra, in which the carbonyl resonance was shifted upfield from δ 176.4 to δ 173.6 and the OH resonance shifted downfield from δ 12.18 to δ 12.72. These findings, together with an IR absorption band at 1718 cm -1 (ester CdO), indicated that compounds 1-6, 9, and 10 are ∆ 9 -THCA esters.
Compound 1 was obtained as a colorless oil, and its molecular formula was determined to be C 32 H 46 O 4 by HRESIMS (m/z 495.3532 [M + H] + ), representing 10 degrees of unsaturation. The 13 C NMR spectrum of 1 revealed 32 carbon resonances, of which 22 corresponded to the ∆ 9 -THCA moiety (assigned through 2 J and 3 J HMBC correlations). A comparison between the 13 C NMR spectra of 1 and ∆ 9 -THCA revealed that the carbon resonances were almost identical, except for an upfield chemical shift of the carbonyl signal from δ 176.4 to δ 173.6. The 10 additional signals were assigned to an oxymethine carbon of the ester moiety at δ 89.6 (C-1′′) and three methyl, three methylene, one methine, and two quaternary carbons. The HMBC spectrum of 1 displayed correlation between H-1′′ (δ H 4.70, s) and the carbonyl carbon (δ C 173.6), indicating that 1 was a monoterpenol ∆ 9 -THCA ester. HMQC and HMBC data suggested that the monoterpenol moiety was fenchol, in which the position of the oxygenated methine (δ C 89.6, δ H 4.70, s) was confirmed by HMBC correlations between H 3 -8′′/C-1′′ ( 3 J CH ), H 3 -9′′/C-1′′ ( 3 J CH ), and H 3 -10′′/C-1′′ ( 3 J CH ). The structure was confirmed by GC-MS: compound 1 spontaneously hydrolyzed and decarboxylated on injection to give ∆ 9 -THC and a monoterpenol. The monoterpenol was identified as -fenchol by library search (NIST), by retention time comparison with an authentic sample, and by comparison with published mass spectra. 27 The trimethylsilyl derivative of 1 showed a molecular ion at m/z 566 in the GC-MS, confirming the HRESIMS result and the presence of one phenolic group. Full assignments of the 1 H and 13 C NMR resonances were completed via analysis of the COSY, HMQC, HMBC, and ROESY spectra (Tables 1 and 2 , Figure 1 ), confirming 1 as -fenchyl ∆ 9 -tetrahydrocannabinolate.
Compounds 2-6, 9, and 10 were isolated as oily compounds, with 1 H NMR (Table 1) , 13 C NMR (Table 2) , and GC-MS data similar to the data for 1, indicating that they also were ∆ 9 -THCA esters. Analyses of the spectroscopic data in the manner described above for 1 led to the structure elucidation of these compounds as epi-bornyl ∆ 9 -tetrahydrocannabinolate (2), R-terpenyl ∆ 9 -tetrahydrocannabinolate (3), 4-terpenyl ∆ 9 -tetrahydrocannabinolate (4), R-cadinyl ∆ 9 -tetrahydrocannabinolate (5), γ-eudesmyl ∆ 9 -tetrahydrocannabinolate (6), bornyl ∆ 9 -tetrahydrocannabinolate (9), and R-fenchyl ∆ 9 -tetrahydrocannabinolate (10) .
The spectroscopic data of 7 and 11 were in accordance with that of CBGA. 28 The ) and four methyl, four methylene, five methine, and one quaternary carbon, indicating that 11 is a sesquiterpenol CBGA ester. GC-MS analysis spontaneously hydrolyzed and decarboxylated 11 to give CBG and a sesquiterpenol. The sesquiterpenol was initially identified as a cadinol isomer via a library search (NIST) and was subsequently found to be R-cadinol through retention time comparison with an authentic sample and by comparison with published mass spectra. 27 GC-MS analysis of the trimethylsilyl derivative of 11 yielded a molecular ion at m/z 636, confirming the presence of one phenolic group in 11. Therefore, the structure of 11 was assigned as R-cadinyl cannabigerolate.
The structure of 7 was similarly elucidated as γ-eudesmyl cannabigerolate based on 1 H NMR, 29 HRESIMS, GC-MS, trimethylsilyl derivatization, and IR data.
The spectroscopic data of 8 were in accordance with that of CBNA, displaying characteristic aromatic protons at δ 8.46 (1H, s, H-10), 7.14 (1H, d, J ) 7.8, H-7), and 7.09 (1H, d, J ) 7.8, H-8) 30 and carbons at δ 127.3 (C-10), 122.5 (C-7), and 128.2 (C-8), indicating, in conjunction with HRESIMS, GC-MS, trimethylsilyl derivatization, and IR data, that 8 was a CBNA ester. Compound 8 was obtained as a yellow oil, and its molecular formula was determined to be C 32 (C-1′′) and three methyl, three methylene, two methine, and one sp 2 quaternary carbon, indicating that 8 was a monoterpenol CBNA ester. GC-MS analysis gave CBN and the liberated monoterpenol. The alcohol was identified as a terpineol isomer via a library search (NIST) and was subsequently found to be 4-terpineol through retention time comparison with an authentic sample and by comparison with published mass spectra. 27 GC-MS analysis of the trimethylsilyl derivative of 8 yielded a molecular ion at m/z 562, confirming the HRESIMS result. On the basis of these observations, 8 was assigned as 4-terpenyl cannabinolate.
In identifying the mono-and sesquiterpene moieties of these esters, an extensive search was undertaken to determine whether these terpenols have previously been found in Cannabis. This was problematic, since in most cases only a general identification was made. For example, fenchol is reported in eight publications as a volatile oil constituent of cannabis, without any indication of stereochemistry, with -fenchol being reported in two publications 31, 32 and R-fenchol not being reported. All reports for borneol are for (()-endo-borneol, 32 as in 9; however 2, which is a C-1′′ epimer of borneol, has not been reported before. (()-R-Terpineol has been reported in numerous publications, 32 with only two publications giving the absolute configuration as (-)-(S), although identification was achieved only via GC-MS analysis. (()-4-Terpineol has also been reported in a number of publications, without any indication of stereochemistry. 32 Cadinol has been reported as the epi-R-isomer (τ-cadinol); 33 however based on GC-MS library data, 27 5 and 11 were identified as R-cadinol esters. γ-Eudesmol has been reported before. 32, 34 Although the cannabis plant has been studied extensively over the past four decades, this is, to the best of our knowledge, the first phytochemical analysis of a high-potency material, 25 and the first newly isolated cannabinoids since 1995, 7 indicating that the high-potency nature of the plant material could open the field to the isolation of other new metabolites.
Biological Activity
The isolated compounds were evaluated for antimicrobial activity 35 (Candida albicans ATCC 90028, Escherichia coli ATCC 35218, Pseudomonas aeruginosa ATCC 27853, Mycobacterium intracellulare ATCC 23068, and Aspergillus fumigat ATCC 90906), as well as antimalarial activity [Plasmodium falciparum (D6 clone) and Plasmodium falciparum (W2 clone)]. 35 The isolated esters and the parent acids were tested for their binding affinity to CB-1 receptor. 36 Compound 8 showed moderate antimicrobial activity against C. albicans ATCC 90028, with an IC 50 value of 8.5 µg/mL, and mild antimalarial activity gainst P. falciparum (D6 clone) and P. falciparum (W2 clone), with IC 50 values of 2.7 and 2.4 µg/mL, respectively. CB-1 receptor binding assay indicated that the esters, as well as the parent acids, are not active.
Experimental Section
General Experimental Procedures. 1D and 2D NMR spectra were recorded in CDCl 3 on a Bruker Avance DPX-500 spectrometer and on a Varian AS 400 spectrometer. IR spectra were recorded on a Bruker Tensor 27 spectrophotometer. UV spectra were obtained on a Varian Cary 50 Bio UV-visible spectrophotometer. Optical rotations were measured at ambient temperature using a Rudolph Research Analytical Autopol IV automatic polarimeter. HRESIMS was obtained using a Bruker Bioapex FTMS in ESI mode.
TLC was carried out on aluminum-backed plates precoated with silica gel F 254 (20 × 20 cm, 200 µm, 60 Å, Merck) and on glass-backed plates precoated with C18 silica gel F 254 (10 × 10 cm, 200 µm, 60 Å, 11% carbon loading, Silicycle). Visualization was accomplished by spraying with Fast Blue B salt (0.5% w/w in H 2O) or p-anisaldehyde [0.5 mL in glacial acetic acid (50 mL) and H 2SO4 (97%, 1 mL)] spray reagent followed by heating. Flash silica gel (40-63 µm, 60 Å, Silicycle) and SiliaBond C18 silica gel (40-63 µm, 60 Å, 17% carbon loading, Silicycle) were used for column chromatography. Analytical HPLC was GC-MS analyses were carried out on a ThermoQuest Trace 2000 GC, equipped with a single split/splitless capillary injector, a ThermoQuest AS2000 autosampler, and a Phenomenex ZB-5 column (30 m × 0.25 mm × 0.25 µm), interfaced to a ThermoQuest-Finnigan Trace MS quadrupole detector. The injector temperature was 250°C, and 1 µL injections were performed in splitless mode, with the splitless time set at 60 s, the split flow set at 50 mL/min, and the septum purge valve set to close 60 s after the injection occurred. The oven temperature was raised from 70 to 270°C (hold 20 min) at a rate of 5°C/min, for a total run time of 60 min; the transfer line temperature was 250°C. Helium was used as the carrier gas at a constant pressure of 20 psi. The mass spectrometer was operated in the electron impact mode (EI Plant Material. Plants were grown from high-potency Mexican C. satiVa seeds (variety code CHPF-01). Whole buds of mature female plants were harvested, air-dried, manicured, packed in barrels (# 1196), and stored at low temperature (-24°C).
Extraction and Isolation. The plant material (9.0 kg) was sequentially extracted with hexanes (2 × 60 L), CH2Cl2 (48 L), EtOAc (40 L), EtOH (37.5 L), EtOH/H 2O (36 L, 1:1), and H2O (40 L) at room temperature. The extracts were evaporated under reduced pressure at 40°C to afford hexanes (1.48 kg), CH2Cl2 (0.15 kg), EtOAc (0.13 kg), EtOH (0.09 kg), EtOH/H2O (0.77 kg), and H2O (0.54 kg) extracts for a total extract of 3.16 kg (35.1%, w/w).
The hexanes extract (0.96 kg) was subjected to VLC on flash silica gel eluting with a hexanes, EtOAc, and MeOH gradient. Reversedphase column chromatography of VLC fraction 4 (hexanes gradient) (7 g) using MeOH as eluent, followed by pooling of fractions with Rf higher than ∆
9
-THC according to silica gel TLC (hexanes/EtOAc, 9:1) and final purification by semipreparative C18 HPLC, afforded 1 (4 mg, tR ) 30 min), 2 (15 mg, tR ) 29 min), fraction A (18 mg, tR ) 22 min), and fraction B (6 mg, t R ) 24 min).
Final purification of fractions A and B through semipreparative chiral HPLC afforded 3 (0.5 mg, tR ) 3 min), 4 (6 mg, tR ) 3.5 min), 5 (3.8 mg, t R ) 4.8 min), 6 (0.7 mg, tR ) 15 min), 7 (0.6 mg, tR ) 14 min) and 8 (1.3 mg, t R ) 20 min) and 9 (1.5 mg, tR ) 4 min), 10 (2 mg, tR ) 4.5 min), and 11 (1 mg, tR ) 17 min), respectively.
Fractions with R f similar to or lower than ∆ 9 -THC according to silica gel TLC (hexanes/EtOAc, 75:25) were combined and purified by flash silica gel chromatography (hexanes, 100%), followed by final purification by semipreparative silica HPLC, to afford ∆ 9 -THC (250 mg), ∆ 9 -THCA (150 mg), CBNA (5 mg), and CBGA (40 mg). 
